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We have been interested in determining the mechanisms by which helper T 
cells collaborate  with  B  cells  in  the  generation  of specific antibody responses. 
Based  on  a  variety  of experimental  approaches  we  have  proposed  that  the 
induction of B cell IgM plaque-forming cells (PFC) ~ responses to protein-bound 
haptens requires two types of helper T  cell signals, the first both antigen specific 
and  B  cell  Ia  restricted  and  the  second  mediated  by  nonspecific factors,  i.e. 
interleukins (1-6).  Studies designed to test the synergistic effects of nonspecific 
factors and antigen-specific helper T  cells have been  complicated because  the 
interleukins may have effects on T  cell functions as well as, or instead of, the B 
cell response under study. 
We previously established the ability of a series ofT cell hybridomas to deliver 
antigen-specific, B cell Ia-restricted helper signals in the PFC response to soluble 
protein  antigens (5).  In  addition  to  the obligate  requirement  for the antigen- 
specific  helper  T  cell  signal,  the  elicitation  of optimal  PFC  responses  was  to 
varying degrees dependent on  the addition of nonspecific factors provided by 
culture supernatants of concanavalin A-stimulated (Con A SN) spleen cells. This 
system offers an ideal opportunity to investigate the effects of nonspecific factors 
on B cell responses to soluble protein antigens under circumstances in which we 
are confident the effects of the factors are on the B cells themselves and not on 
the T  cell hybridomas. 
Our primary approach to studying the interleukins involved in the generation 
of specific B cell antibody responses has been the primary in vitro PFC response 
to sheep erythrocytes (SRBC). Unlike the antibody response to soluble proteins, 
spleen Con A  SN are sufficient to drive the anti-SRBC PFC response of T  cell- 
depleted splenic B cells (6).  Using splenic B cells rigorously depleted of T  cells 
and macrophages (MO) we have been able to replace the activity of spleen Con 
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A  SN  with  a  combination  of three nonspecific factor preparations  (7-9).  The 
first preparation is the culture SN of the MI0 tumor cell line P388D1 (P388 SN), 
the second the interleukin 2 (IL-2) containing Con A SN of the T  cell hybridoma 
FS6-14.13 (FS6 SN) and  the third,  the interleukin X  (IL-X) containing Con A 
SN of the T  cell hybridoma FS7-20.6.18 (FS7 SN). These data suggested that at 
least three interleukins contribute to the PFC response to SRBC and that their 
effects can be mediated directly on the B cells themselves. 
In  this  paper  we  demonstrate  the  synergy  of these  same  three  nonspecific 
factor preparations in the antigen-specific helper T  cell-dependent PFC response 
to protein-bound haptens. These data confirm that antibody responses to SRBC 
and  protein-bound  haptens  share  similar  nonspecific factor requirements,  but 
that for responses to soluble protein antigens an antigen-specific H-2-restricted 
T  cell activity is required as well. 
Materials and Methods 
Mice.  B10.D2nSN, C57BL/6J, and C57BL/10SgSn mice were purchased from the 
Jackson  Laboratory,  Bar  Harbor,  ME.  B6D2Fj  mice  were  bred  in  our  facility from 
breeding stock obtained from the Jackson Laboratory. 
Antigens  and  Other Reagents.  Concanavalin  A  (Con  A)  was  purchased  from  Miles 
Laboratories,  Inc.,  Elkhart,  IN;  Escherichia coli lipopolysaccharide (LPS)  from  Difco 
Laboratories, Detroit, MI; 2-4-6-trinitrobenzenesulfonic acid (TNP)from Pierce Chemical 
Co., Rockford, IL; keyhole limpet hemocyanin (KLH) from Calbiochem-Behring Corp., 
American  Hoechst Corp.,  San  Diego,  CA  a-methyl-n-mannoside (a-MM),  and  human 
gamma globulin (HGG) Cohn fraction II from Sigma Chemical Co., St. Louis, MO. Horse 
erythrocytes (HRBC) from a single animal were obtained from the Colorado Serum Co., 
Denver, CO. TNP-LPS was preparaed by the method of Rittenberg and Amkraut (10) as 
modified by Jacobs and  Morrison  (11).  TNP-HGG and  TNP-KLH were prepared as 
previously described (1). TNP-HRBC were prepared as described by Rittenberg and Pratt 
(12). 
Immunizations.  Splenic B cells were immunized for anti-TNP IgM responses by intra- 
peritoneal injection of 10 #g TNP-LPS 7 d before use. 
Cell Preparations.  To prepare  hapten-primed  B  cells  depleted of both T  cells  and 
macrophages, TNP-LPS-primed mice were given an 0.4 ml injection of a 1:10 dilution of 
rabbit  anti-mouse  thymocyte serum  (Microbiological Associates,  Walkersville,  MD)  in 
Hank's balanced salt solution (HBSS), 3-4 d  before use.  Spleen cell  suspensions from 
these mice were passed over Sephadex G 10 columns (13), treated with a cocktail of anti- 
T cell antibody reagents for 30 min on ice, incubated with a 1:15 dilution of rabbit serum 
as the complement source (Grand Island Biological Co., Grand Island, NY) for 30 min at 
37 ° C, washed, and then resuspended in medium. The antibody cocktail was similar to 
that previously described (I 4), containing rabbit anti-mouse thymocyte serum, T24/40.7 
anti-Thy-1 monoclonal antibody (Dr. Ian Trowbridge, Salk Institute, La Jolla, CA),  MK 
2.2  anti-"Qa like"  monoclonal antibody, B16/146  anti-Qat-4 ascitic fluid (Dr.  Ulrich 
Hfimmerling, Sloan-Kettering Memorial Cancer Institute, New York, NY), and ADH-15 
anti-Lyt-2.2 ascites fluid (Dr. Paul Gottlieb, University of Texas, Austin, TX). 
Cell Culture.  2 ×  106 hapten-primed, T  cell- and macrophage-depleted splenic B cells 
were cultured  in  0.5  ml  medium  in  Linbro  76-033-05  24-wetl  culture plates (Linbro 
Chemical Co., Hamden, CT). Irradiated (1,300 rad) hybridoma T cells were added in the 
range of 0.5 to 2.0 x  10 s per well. Culture conditions were modified from those of Mishell 
and Dutton (15, 16). Cultures contained 2.0 ~g/ml TNPT-HGG or 0.2 #g/ml TNP-KLH 
as antigen. To prevent effects due to residual Con A in nonspecific factor preparations, 
c~-MM was added to all cultures at a final concentration of 10 mg/ml. 
Assay  for Plaque-forming Cells (PFC).  On day four of culture, anti-TNP direct PFC were 
assayed by a slide modification of theJerne hemolytic plaque assay using TNP-conjugated ROEHM  ET  AL.  319 
HRBC (15). 
T Cell I4ybridomas.  AODH7.1, AODK 10.4,  and BDK 11.1 the antigen-specific, H-2- 
restricted  T  cell  hybridomas  used  in  these  experiments  were  prepared  as  previously 
described (17,  18). AODH 7.1 is specific for the antigen HGG and I-E  d restricted; AODK 
10.4 is specific for KLH and I-A  d restricted; and BDK 11.1 is specific for KLH and I-A  b 
restricted.  The  Con  A-inducible T  cell  hybridomas  FS6-14.13  and  FS7-20.6.18  were 
prepared as previously described (8,  17). 
Nonspecific Helper Factors.  Culture supernatants of Con A-stimulated spleen cells (spleen 
Con A SN) were prepared as previously described (6). B6D2Fj spleen cells at 107/ml in 
complete medium with 5% fetal  calf serum, were cultured for 24 h with 4 ~g/ml Con A. 
Cell-free SN were then harvested and stored at -20°C. 
Macrophage-derived helper factor(s)  were obtained as  the constitutive culture SN of 
the MO tumor cell line P388D1  (P388 SN) (19).  P388D~ were cultured at 2 X 106/ml in 
complete medium containing 1% fetal calf serum. After 6 d of culture the cell free SN 
was harvested and stored at -20°C. This factor preparation has previously been shown 
to enhance the primary in vitro anti-SRBC PFC response of T  cell- and MO-depleted B 
cells (7). While we have not characterized the active component(s) of P388 SN in the anti- 
hapten  PFC  assay,  the  available  evidence  suggests  that  it  is  similar  to  the  monokine 
interleukin  1 (20). 
Interleukin  2  (IL-2) containing SN  were prepared  from the  T  cell  hybridoma FS6- 
14.13 (FS6 SN) as previously described (14, 17). FS6-14.13 at 106/ml in complete medium 
containing 0.5% fetal calf serum were stimulated with 3/~g/ml Con A for 24 h. Based on 
the method of Watson et al. (21),  the cell-free SN was made 0.1  M with a-MM and then 
(NH4)2SO4 was  added  to  40%  saturation.  The  resulting  precipitate  was  removed and 
(NH4),,SO4 added to the remaining SN to 80%  saturation.  The second precipitate  was 
resuspended in 0.15 M NaCI and then extensively dialyzed against 0.15 M NaCI and then 
against HBSS.  The overall concentration of the FS6 SN was ~50×. 
The T cell growth-stimulating activity of FS6 SN was assayed using the IL-2-dependent 
T cell line HT-2, kindly provided by Dr. James Watson (Auckland, New Zealand; 14,  18, 
22, 23). Cultures containing 100 ul twofold dilutions of SN were incubated for 24 h with 
4,000 viable  HT-2 cells. The first twofold dilution to yield <90% viable  HT-2 cells was 
defined as  containing  !  U  IL-2. The concentrated FS6  SN  used  in  these experiments 
contained 25,000-50,000 U IL-2/ml. 
FS6 SN were depleted of IL-2 by incubation with HT-2 cells at 5 ×  105/ml for 40 h at 
37°C, at  which time the  SN contained <10  U/ml IL-2 (limit  of detectability in  HT-2 
assay). The cell free SN was harvested and concentrated as described above. 
Interleukin  X  (IL-X) containing factor preparations  were  Con  A  SN  of the  T  cell 
hybridoma FS7-20.6.18 (FS7 SN).  The Con A SN were prepared by stimulation of FS7- 
20.6.18 at  106 cells/ml with 4 #g/ml Con A in complete medium containing 10% fetal 
calf serum. After 24 h the cell free supernatants were harvested and stored at -70°C. 
Con  A  stimulation  of FS7-20.6.18  has  been  shown  to  lead  to  the  production  of 
interferon-~, (IFN~), MO-activating factor (MAF), Ia-inducing factor (IaIF), and the B cell 
helper factor IL-X (8). The coordinate expression of these four lymphokine activities  in 
subclones of FS7-20, their pH 2 sensitivities,  and their frequent independent segregation 
from the production of IL-2 suggests either IFN,, MAF, IaIF, and IL-X are all activities 
mediated by a single factor or alternatively, two or more of these activities  are mediated 
by different factors, the production of which is controlled by a common genetic mechanism 
(8). As a  point  of clarification,  the  functional  activities  of FS7-20.6.18  are  not  to  be 
confused with  FS7-6.18, an independent T  cell  hybridoma prepared in  our laboratory, 
whose activities  have been described by Isakson et al. (24). 
Based on titration  curves relating the  virus agglutination titer  to  the  log of the  SN 
volume (25),  FS7  SN  contained  480  international  units  IFN/ml as  compared  with  a 
National  Institutes  of Health  (NIH) reference B-interferon  (#G-002-904-511).  FS7  SN 
contained <10 U/ml IL-2 as defined in the HT-2 assay (see above). 
FS7 SN sensitivity  to pH 2 neutralization utilized the method of Klein  et al. (26).  SN 320  HELPER SIGNALS IN  B CELL ANTIBODY RESPONSES 
were dialyzed for 24 h against 0.1  M glycine-HCl, 0.15 M NaCI, pH 2.0 buffer, followed 
by dialysis for 48 h against HBSS, pH 7.2 and then Mishell-Dutton media. 
Results 
Previous studies demonstrated the ability of the T  cell hybridoma AODH 7.1 
to deliver an  HGG-specific,  I-Ed-restricted helper signal in the anti-TNP  PFC 
response of hapten-primed, T  cell-depleted B10.D2  B cells and MO-stimulated 
with  TNP-HGG  (5).  In  this  system significant anti-TNP  PFC  responses  were 
elicited in  the absence of added nonspecific factors; however the addition  of 
spleen  Con  A  SN  substantially  increased  these  responses.  We  subsequently 
observed that the elicitation of anti-TNP PFC to TNP-HGG, driven by AODH 
7.1, could be rendered completely dependent on the addition of the nonspecific 
factors in spleen Con A SN by using B cells depleted of MO by G10 passage and 
rigorously depleted of T  cells by treatment with anti-thymocyte serum in vivo 
and a cocktail of anti-T cell antibodies in vitro. 
Sv,~ergy of Three Nonspecific  Factor Preparations  with  the Antigen-specific  Helper T 
Cell Iqybridoma.  Using this system we began analysis of the required nonspecific 
factors present in spleen Con A  SN.  Our approach was based on the previous 
demonstration that a combination of three nonspecific factor preparations could 
substitute for spleen Con A SN in the generation of a primary PFC response to 
SRBC (7-9). Fig. 1 demonstrates the ability of this combination of three nonspe- 
cific factor preparations; P388 SN, FS6 SN, and FS7 SN, to substitute for spleen 
Con A SN in the antigen-specific helper T  cell-dependent PFC response to TNP- 
HGG.  Three points are relevant to this data.  First, no combination of factors 
substituted for the requirement for the antigen-specific helper signal provided 
by AODH 7.1. Second, in the presence of AODH 7.1, the generation of optimal 
anti-TNP  PFC  responses required the addition of all  three nonspecific factor 
preparations, i.e. P388 SN + FS6 SN + FS7 SN and in combination, their activity 
was substantially greater than that of spleen Con A  SN.  Third,  the anti-TNP 
PFC response elicited upon addition of all three factor preparations at optimal 
concentrations and times, was linearly related to the number of AODH 7.1  cells 
added. 
Fig.  2  summarizes the available data regarding the relative contribution  of 
each helper component. As mentioned above, the elicitation of PFC responses 
required the antigen-specific helper signal  provided by the T  cell hybridoma 
AODH  7.1  in  conjunction with  the  nonspecific factors.  In  combination  with 
AODH  7.1,  each of the nonspecific factor preparations  alone had a  minimal 
effect on the generation of anti-TNP PFC responses to TNP-HGG.  When the 
nonspecific factor preparations  were  used in  paired  combinations,  significant 
PFC responses were observed that approached those elicited with spleen Con A 
SN. Comparison of the anti-TNP responses elicited with AODH 7.1  and paired 
combinations of the factor preparation  suggests the relative stringency of the 
requirement for each preparation was P388 SN >  FS6 SN >  FS7 SN. When all 
three nonspecific factor preparations  were used in  combination, their activity 
was at least four times greater than that of spleen Con A SN or any of the paired 
combinations of factor preparations. 
H-2  Restriction  of Antigen-specific  Help.  In  these  studies  we  confirmed that ROEHM  ET  AL.  321 
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FIGURE  1.  Titration of the HGG-specific, I-Ed-restricted helper T  cell hybridoma  AODH 
7.1  in the presence of various combinations of the nonspecific factor preparations.  Hapten- 
primed,  T  cell- and  MO-depleted  B10.D2  B  cells were stimulated  with  TNP-HGG in  the 
presence of the indicated number of irradiated AODH 7.1  hybridoma cells and the indicated 
nonspecific factor preparations  added  at  optimal  times and  concentrations.  The  anti-TNP 
PFC/cuhure were determined on day 4 of incubation.  The combinations  of  factor preparations 
were: P388 SN + FS6 SN + FS7 SN (e), P388 SN + FS6 SN (T), FS6 SN + FS7 SN (A), P388 
SN + FS7 SN (V), P388 SN (V1), FS6 SN (Q)), FS7 SN (O), spleen Con A SN (B), or nothing 
(zx). 
delivery of the antigen-specific helper signal  by the T  cell  hybridomas, in  the 
presence of the nonspecific factor preparations,  was restricted by H-2 antigens 
expressed  by  the  responding  B  cells.  Two  KLH  specific hybridomas,  AODK 
10.4 which is I-A  d restricted and BDK  11.1  which is I-A  b restricted, were used 
as a  reciprocal pair to test their requirements for H-2 identity with the hapten- 
specific B cells stimulated with TNP-KLH. As shown in Fig. 3, the I-Ad-restricted 
hybridoma AODK  10.4  stimulated the hapten-specific  PFC responses  by H-2 d 
B10.D2  B  ceils,  but  not  H-2 b B10  B  cells even  in  the  presence  of functional 
B 10. D2 antigen-presenting cells. Conversely, the I-Ab-restricted hybridoma BDK 
11.1  stimulated PFC responses by H-2 b B10 B cells, but not H-2 d B10.D2 B cells 
even  in  the  presence  of functional  B10  antigen-presenting cells.  In  each  case 
controls demonstrated that the presence  of H-2  disparate  B  cell/MO did not 
inhibit PFC responses generated by nonirradiated B cells and the appropriate T 
cell hybridoma. In addition, control experiments demonstrated the ability of the 
irradiated  B  cell/MO  to  present  KLH  to  the  appropriate  T  cell  hybridoma, 
although  they were  not able  to develop  into  PFC.  We concluded that  in  the 
presence  of the three  nonspecific factor preparations,  delivery of the antigen- 
specific helper signal  was restricted by H-2  antigens expressed  on  the hapten- 
specific B cells. Similar results have been obtained using AODH 7.1. 322  HELPER  SIGNALS  IN  B  CELL  ANTIBODY  RESPONSES 
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Ability  of various  combinations  of nonspecific  factor  preparations  to  replace 
spleen Con A SN in the antigen-specific helper cell dependent PFC response to protein-bound 
hapten. Hapten-primed, T  cell- and MO-depleted B10.D2 B cells were stimulated with TNP- 
HGG in  the presence of optimal concentrations  of irradiated  AODH  7.1  hybridoma  cells 
(HGG,  1-Ea). The  indicated  helper  factor  preparations  were  added  at  optimal  times  and 
concentrations.  On  day  4  of incubation  the anti-TNP  PFC/culture  were  determined  and 
expressed as a percentage of the maximal response. Data summarize 12 experiments. 
Requirement for Linked Recognition.  In a representative experiment presented 
in  Fig.  4  we demonstrate  that  in  the presence of the  three  nonspecific  factor 
preparations, delivery of the antigen-specific helper signal by AODH 7.1 required 
linked recognition of the hapten-carrier TNP-HGG. Stimulation with either free 
HGG or TNP conjugated to the irrelevant carrier KLH plus free HGG over the 
range  of 2  to  1,000 #g/ml  elicited marginal  PFC responses as compared  with 
TNP-HGG. The immunogenicity of the TNP-KLH in the PFC response of these 
B cells was demonstrated  using the KLH specific hybridoma AODK  10.4.  The 
HGG was also demonstrated to be immunogenic based on the IL-2 response of 
AODH 7.1 in the presence of irradiated B10.D2 spleen cells. We concluded that 
delivery of the  HGG  specific helper  signal  in  the  presence  of the  nonspecific ROEHM  ET  AL. 
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FIGURE 3.  Delivery of the antigen-specific helper signal by T cell hybridomas in the presence 
of the nonspecific factor preparations was restricted by H-2 antigens on the responding B cells. 
Irradiated AODK  10.4 (KLH,  DA  d) or BDK  11.1 (KLH,  I-A  b) were titrated  into  Mishell- 
Dutton cultures stimulated with TNP-KLH in the presence of optimal concentrations of P388 
SN, FS6 SN, and FS7 SN nonspecific factor preparations.  The responding hapten-primed,  T 
cell- and MO-depleted,  B10 (H-2  b) or B10.D2 (H-2  d) splenic B cells were assayed for their 
anti-TNP PFC response in the presence of irradiated  (4,000 rad) B10 or B10.D2 B cell/MO 
as a source of antigen presenting cells. Control experiments demonstrated  that the irradiated 
B cell/MO were functional in the presentation of KLH to the appropriate T cell hybridoma. 
Data are expressed as the expected anti-TNP PFC per culture per l0  s cells _+ SE. 
helper factors required  linked recognition of the hapten-carrier conjugate. 
Kinetic Analysis of Helper Component Addition.  Kinetic  analysis of the  time  of 
addition  of  each  helper  factor  preparation  in  the  primary  anti-SRBC  PFC 
response  indicated  that  the  interleukins  present  in  P388  SN  and  FS6  SN  act 
early in the response, while IL-X (provided by 4-d spleen Con A SN) was a  "late" 
acting  factor  (7).  We  have  reached  similar  conclusions  with  respect  to  the 
nonspecific factor requirements in the  PFC response to protein-bound  haptens. 
In  the  experiments  summarized  in  Fig.  5,  the  time  of addition  of one  helper 
component  was  varied  and  each  of the  remaining  components  were  added  at 
optimal times and concentrations.  A  24-h or 48-h delay in the addition of P388 
SN  (panel A),  FS6  SN  (panel B) or the  T  cell hybridoma  AODH  7.1  (panel D) 324  HELPER  SIGNALS  IN  B  CELL  ANTIBODY  RESPONSES 
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FIGURE 4.  Requirement for linked recognition of hapten-carrier in the delivery of antigen- 
specific help by the HGG/I-E  d specific hybridoma AODH 7.1.  Hapten-primed,  T  cell- and 
MO-depleted B10.D2  B cells were stimulated with the indicated antigens in the presence of 
AODH 7.1  and optimal concentrations of the three nonspecific factor preparations:  FS6 SN 
+  FS7 SN +  P388  SN.  Data are expressed as a  percentage of the optimal response elicited 
following titration of AODH 7.1  and calculation of the expected anti-TNP PFC/culture/108 
hybridoma cells,  lmmunogenicity of TNP-KLH demonstrated using AODK 10.4 (KLH/I-A  a) 
and  the same  B  cell pool  (7,757  +  1,299  anti-TNP  PFC/culture/106  AODK  10.4  cells). 
lmmunogenicity of HGG demonstrated using the IL-2 response of AODH 7. I and irradiated 
B10.D2 spleen cells as antigen-presenting cells (1,280  U 1L-2/ml at 1 mg/ml HGG). ROEHM  ET  AL.  325 
A. 
I00.. 
80- 
60- 
~"  40- 
20- 
. F  ~÷FST  ~4 
0 
NONE  O  I  2 
o:  ADDED 
~  c. 
x  F$7 
1  " 
~  80- 
~  • 
60- 
40- 
20-  P~8 ~  + F,,~,~ 
0 
NONE  O  I  2 
ADDED 
B. 
P388 SN + FS7 SN 
NONE  O  I  2 
ADOED 
D. 
P~8 SN "1-  \ 
NONE  0  I  2 
ADOED 
TIME OFADDITION OF FOURTH COMPONENT (DAY) 
FIC;URE 5.  Kinetics  of addition of helper component•  In each panel a set of hapten-primed, 
T  cell- and MO-depleted B10.D2 B cells were stimulated with TNP-HGG in the presence of 
optimal concentrations of irradiated AODH 7.1  hybridoma cells (HGG, I-Ea). In panels A, B, 
and C each culture received two of the three helper preparations at optimal concentrations 
and  times  and  the  third  factor  preparation  was  either  not  added  or  added  at  optimal 
concentrations on day 0, 1, or 2. In panel D, each of the three factor preparations were added 
at optimal concentrations and times and the helper T  cell hybridoma AODH 7.1  was either 
not added or added on day 0,  1, or 2. Anti-TNP PFC/culture were determined on day 4 of 
incubation. Following titration of AODH 7.1  the expected anti-TNP PFC/culture/10  6 hybri- 
doma cells were calculated and the data expressed as a percentage of the optimal response• 
Data were pooled from two similar experiments, 
significantly reduced the anti-TNP  PFC  response observed on day 4.  In each 
case the longer the delay in addition of each of these helper components, the 
greater the reduction in the PFC response. 
In  contrast  to  the  early requirement for  the antigen  specific helper signal 
provided by AODH 7.1  and the nonspecific helper factors in P388 SN and FS6 
SN, the helper factor(s) provided by FS7 SN appeared to be "late" acting. Thus 
addition  of FS7  SN  at  24  h  of culture  resulted  in  significantly greater  PFC 
responses than addition at the initiation of culture or at 48 h. 
Titration of Nonspecific Factor Preparations.  Further support for the conclusion 
that the independent effects of each nonspecific helper factor preparation were 
in fact due to qualitative rather than quantitative differences in the interleukins 
they contain  is  presented in  Fig.  6.  In  each panel  of Fig.  6  two of the three 
helper factor preparations were added at optimal concentrations (P388 SN 20%, 
FS6 SN 2%, and FS7 SN 20%) and times and the third factor preparation was 
titrated into the cultures at its optimal time of addition. Titration of each helper 326  HELPER  SIGNALS  IN  B  CELL  ANTIBODY  RESPONSES 
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FIGURE 6.  Titration of nonspecific factor preparations. In each panel a set of hapten-primed, 
T  cell- and MO-depleted BI0.D2 B cells were stimulated with TNP-HGG in the presence of 
optimal  numbers  (1.5  x  105) of irradiated  AODH  7.1  hybridoma  cells (HGG,  l-Ed).  Each 
culture received two of the three nonspecific helper factor preparations at optimal concentra- 
tions (P388 SN 20%, FS6 SN 2%, and FS7 SN 20%) and the third preparation  was titrated. 
Each factor preparation was added at optimal times. Cultures were assayed for anti-TNP PFC/ 
culture on day 4 of incubation. Data were pooled from three similar experiments. 
factor  preparation  confirmed  that  the  concentrations  used  were  in  fact  near 
saturation. These results substantiate the conclusion that even in the presence of 
optimal  concentrations  of two of the nonspecific factor preparations,  the third 
factor preparation  was required for a maximal response. 
Characterizatio~  of Active  Components in  FS6  SN  and  FS7  SN.  Independent 
studies have established that  FS6 SN contained high  concentrations of IL-2 as 
determined in a T  cell growth factor (TCGF) assay and lack significant levels of 
IFN~ as determined by the inhibition of virus replication, while conversely, FS7 
SN contain high concentrations of IFN  v and low levels of IL-2 (reference 8 and 
unpublished observations). In view of this information we attempted to establish 
further that the activity of FS6 SN and FS7 SN in the PFC response to protein- 
bound haptens were due to IL-2 and IFNu, respectively. These data are presented 
in Fig. 7. 
Part  of an  aliquot  of  FS6-14.13  Con  A  SN  was  absorbed  with  the  IL-2 
dependent T  cell line HT-2 and then concentrated by (NH4)2804 precipitation 
in  parallel  with  an  unabsorbed control  aliquot.  The  unabsorbed  FS6 SN con- 
tained  25,600  U  of IL-2  per  ml  and  the  HT-2  absorbed  FS6 SN  400  U/ml. 
These two nonspecific factor preparations were titrated into cultures of hapten- 
primed  B  cells,  AODH  7.1,  P388  SN,  and  FS7  SN,  all  added  at  optimal 
concentrations and times. As shown in panel A of Fig.  7, IL-2 depletion of FS6 
SN  resulted  in  the  loss of most but  not all  of its  activity as compared  to  the 
unabsorbed FS6 SN control. The significant reduction in FS6 SN activity upon 
absorption with an  IL-2-dependent  T  cell line suggests that  IL-2 is one of the 
active components of this nonspecific factor preparation.  The fact that the HT- 
2  absorbed  FS6  SN  had  some residual  activity has  two possible explanations. 
First,  AODH  7.1  is known  to be capable of making  IL-2 (18) although  at this 
low antigen  concentration,  with this population of B cells as antigenaWesenting 
cells and following irradiation,  the ability of AODH 7.1  to make IL-2 is known 
to  be  substantially  reduced  if not  abrogated.  Second,  FS6  SN  may  contain  a 
second  factor,  which  in  addition  to  IL-2,  is  active  in  this  assay  system  (see ROEHM  ET  AL.  327 
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FIGURE 7.  Characterization of active components in FS6 SN and FS7 SN.  In panels A and 
B, hapten-primed, T  cell-and MO-depleted BI0.D2 B cells were stimulated with TNP-HGG 
in the presence of optimal numbers of irradiated AODH  7.1  hybridoma cells (HGG,  I-Ed). 
Panel A.  Effect of IL-2 depletion of FS6  SN.  Half of a  pool of FS6-14.13  Con  A  SN  was 
absorbed with the IL-2-dependent T  cell line HT-2 as described in Materials and Methods. 
The IL-2-depleted SN was then concentrated in parallel with an unabsorbed control SN by 
(NH4)~SO4  precipitation.  The  control  and  IL-2-depleted  FS6  SN  were  then  titrated  into 
cultures containing P388 SN and FS7 SN added at optimal concentrations and times, Panel 
B.  Sensitivity of FS7 SN  to pH  2  incubation. Half of a  pool of FS7-20.6.18  Con A  SN was 
dialyzed against pH  2 glycine-HCl buffer and the other half dialyzed against pH  7.2  HBSS. 
Both of these SN were further dialyzed against HBSS and then culture medium. At 24 h  of 
incubation these two preparations of FS7 SN were titrated into cultures containing P388 SN 
and FS6  SN added at optimal concentrations and times.  On day  4  of incubation anti-TNP 
PFC/cuhure were determined. 
discussion). 
A  characteristic feature of IFN, activity is its pH 2 sensitivity (26,  27).  In an 
attempt to discern the pH 2 sensitivity of FS7 SN activity in the PFC response 
to protein-bound baptens, one half of an aliquot of FS7-20,6.18  Con A SN was 
dialyzed against pH 2 glycine-HCl buffer and the other half dialyzed against pH 
7.2 HBSS.  Each preparation was then further dialyzed against HBSS and then 
Mishell-Dutton media.  The control and pH  2-incubated FS7  SN were titrated 
into cultures (at 24 h of incubation) of hapten-primed B cells, AODH 7.1, P388 
SN, and  FS6  SN, all added at optimal concentrations and  times. As shown in 
panel B  of Fig.  7,  pH  2  incubation  of FS7  SN  abrogated  its  activity  in  the 
generation ofanti-TNP PFC as compared to the dialyzed control FS7 SN. Mixing 
experiments (data not shown) established that the pH  2-incubated FS7 SN was 
not inhibitory in these cultures. These results support the conclusion that IFN, 
is an active component of FS7 SN in this system. 
Discussion 
On the basis of a  variety of experimental approaches, we have proposed that 
antigen-primed T  ceils mediate two types of helper activities (1-6). One of these 
activities was first detected by the ability of antigen-primed T  cells, upon specific 
restimulation, to nonspecifically drive the bystander B cell response to erythro- 
cyte-bound antigens (1). This antigen nonspecific helper activity could be found 
in cell-free culture SN following specific challenge of antigen-primed T  cells as 
well as following Con A  stimulation of normal T  cells (6).  We have identified 328  HELPER  SIGNALS  IN  B  CELL  ANTIBODY  RESPONSES 
three nonspecific factor preparations (FS6 SN, FS7 SN, and P388 SN) which in 
combination, will substitute for spleen Con A SN in the anti-SRBC PFC response 
of T  ceil- and M~O-depleted B cells (7-9). These results suggested that at least 
three interleukins act on B cells in the generation of PFC responses to SRBC. 
In addition to nonspecific factors, a second type of activity, "antigen-specific 
help", was implicated in the PFC response to protein-bound haptens (1-6). While 
nonspecific factor preparations such as spleen Con A SN were sufficient to drive 
the  anti-hapten  PFC  response  to  TNP-SRBC,  they  were  insufficient  in  the 
response to TNP conjugated to proteins such as HGG or keyhole limpet hemo- 
cyanin. Based on a series of experiments utilizing limiting dilution, differences 
in the antigen dose response for priming and challenge, as well as differential 
fine  specificity, we  concluded that  the  two  types of helper activity  could  be 
mediated by different T cells (1-3, 28). This conclusion received further support 
by the observation  that anti-Ia sera raised against Con  A  blasts,  eliminated a 
population of helper T  cells whose function could be replaced by spleen Con A 
SN (4).  Since spleen Con  A  SN  was insufficient by itself, this again suggested 
that at least two types of helper function were involved at the effector phase in 
the PFC response to hapten-protein conjugates. 
Subsequently  we  described  the  ability  of a  panel  of T  cell  hybridomas  to 
mediate antigen-specific help in the PFC response to protein-bound haptens (5). 
Delivery of the antigen-specific signal  by  the  T  cell  hybridomas was  carrier- 
specific and restricted by Ia antigens expressed on the hapten-specific B cells, 
suggesting that direct T  cell/B cell contact was essential to deliver this helper 
signal. With a number of T  cell hybridomas in the panel, the generation of anti- 
hapten PFC responses required the addition of nonspecific factors provided by 
spleen Con A  SN.  Since the hybridomas grow constitutively in the absence of 
exogenous growth factors, the requirement for nonspecific factors in addition to 
the carrier/I specific helper T  cell hybridoma again supported the conclusion 
that two types of helper signals were required for this B cell response. 
The present study attempted to determine the nature of the nonspecific factors 
required in the PFC response to protein-bound haptens. Our approach was based 
on the ability of three nonspecific factor preparations to fully replace the helper 
activity of spleen Con  A  SN  in anti-SRBC  PFC  responses of T  cell- and MO- 
depleted B cells (7-9). The results presented demonstrate that the elicitation of 
hapten-specific PFC  responses to TNP-protein conjugates by T  cell- and MO- 
depleted, hapten-primed B cells requires both an antigen-specific helper signal 
provided by a  T  cell  hybridoma as well as  nonspecific helper factors.  In  the 
absence of either of these helper activities, significant PFC responses were not 
observed. The elicitation of optimal anti-hapten responses required addition of 
all three nonspecific factor preparations: FS6 SN +  FS7 SN +  P388 SN. 
In an attempt to confirm a qualitative requirement for each helper component 
in  the  PFC  response  to  TNP-HGG,  three of the components were added at 
optimal concentrations and times and the fourth was titrated into cultures at its 
optimal time of addition. The titration data (Figs.  1 and 4) show that each helper 
component was used near saturation and that in the presence of optimal concen- 
trations of three of the helper components, the PFC response was directly related 
to the amount of the fourth component added. This result further substantiates ROEHM  ET  AL.  329 
the conclusion that there was a qualitative requirement for at least three nonspe- 
cific factors in  addition  to an antigen-specific helper signal in  the response to 
protein-bound  haptens.  Delivery  of the  antigen-specific helper  signal  in  the 
presence of the  three  nonspecific factor  preparations  was  shown  to  be  both 
carrier specific and B cell I-region restricted. 
The nonspecific factor requirements provided by the combinations of FS6 SN 
+  FS7 SN +  P388  DN, in the generation of optimal PFC responses to protein- 
bound haptens, directly parallel observations regarding the generation of anti- 
SRBC PFC responses. In addition kinetic experiments indicated that these three 
activities acted at similar times in both the anti-SRBC and the anti-TNP-protein 
responses. Thus the P388  SN had to be added very early to be effective. The 
FS6 SN was also required early, but the FS7 SN was optimal when added at day 
one of the 4-d response.  The antigen-specific/I-region-restricted help was re- 
quired from the initiation of the B cell response. 
These experiments argue very strongly against the view that the helper T  cell 
activity mediated via iymphokines and that mediated via direct antigen/I-region 
recognition by T  cells on the B cell surface represent alternate helper pathways. 
Rather, they are consistent with our previously proposed model in which B cells 
may be activated either by efficient immunogiobulin cross-linking antigens such 
as  SRBC  or  by  T  cell  contact with  antigen/I-region  products  on  the  B  cell 
surface. B cells activated by either pathway become equally dependent on a set 
of lymphokines in  order to  complete their response  to  the point  of antibody 
secretion. 
The identity of the lymphokines in  each of our factor preparations has not 
been established finally; however, we have performed some partial  characteri- 
zations. It seems likely that the activity in P388 SN is IL-1 or IL-l-like molecules. 
We have not always found a  direct correlation between the level of activity in 
these SN in our PFC responses vs.  their activity in thymocyte proliferation assays, 
but  G-75  chromatography of the SN  has shown  the active component in  the 
SRBC response in fractions corresponding to 15,000 tool wt. 
The Con A  SN of the T  cell hybridoma FS6-14.13  is known to have at least 
two lymphokine activities, T  cell growth or IL-2 (17) and B cell growth factor 
(BCGF) (29, 30). It was previously inferred that IL-2 was an essential component 
of FS6 SN in the PFC response to SRBC on the basis of the ability of activated 
T  cells or the  IL-2-dependent T  cell line  HT-2,  to deplete this  B cell helper 
activity in parallel with TCGF activity (17). This conclusion was also supported 
by the coordinate expression of these activities both qualitatively and quantita- 
tively in independent T  cell hybridomas and their subclones. In addition, Seph- 
adex chromatography of FS6 SN indicated that its IL-2 activity as measured by 
its ability to support the growth and viability of HT-2 cells, emerged at 30-40 
kdaltons in the same column fractions as the B cell helper activity. 
We have recently confirmed the presence of BCGF activity in FS6 SN, defining 
this activity similarly to Parker (29). As reported by Howard et al. (31) we have 
found the BCGF in FS6 SN to be '~, 15-20 kdaltons by Sephadex chromatogra- 
phy. The characterization of this activity in  various PFC responses will be the 
subject of another report,  but  it  is  worth  pointing out  that  partially purified 
BCGF  is in our hands inactive in  replacing IL-2  in anti-SRBC  PFC responses, 330  HELPER SIGNALS 1N  B CELL ANTIBODY RESPONSES 
nor have we yet found a synergy between IL-2 and BCGF. In the present study 
the preparation of concentrated, T  cell-absorbed FS6 SN was virtually devoid of 
IL-2 but retained  ~50% of its BCGF activity. Nevertheless it was unable at any 
concentration to replace the FS6 SN in the anti-TNP  PFC response. This again 
indicated that IL-2 was one of the essential factors in the SN. It is worth noting, 
however, that after IL-2 removal this SN had more stimulatory residual activity 
than  we would have  predicted  from  our previous experience  with  anti-SRBC 
PFC  responses.  In  fact  this  very batch  of IL-2-deficient  SN  was without  any 
residual activity in anti-SRBC PFC responses. It is possible that anti-TNP protein 
responses are  more sensitive to  BCGF than  anti-SRBC  responses,  a  possibility 
that can be tested after further purification of these two activities. 
As has  been  the  case for a  number  of years now,  we are  in  a  quandary  to 
explain the role of IL-2 in B cell responses. There is no direct evidence that  B 
cells can interact with IL-2 so that it has been widely suggested that IL-2 acts by 
revealing a hidden T  cell activity in even the most scrupulously purified B cells. 
These and our previous studies would appear to eliminate BCGF and the factors 
in  FS7 SN as the activities released by this contaminating  T  cell.  Furthermore 
the  current  studies  would  seem  to  eliminate  an  antigen-specific/I-region-re- 
stricted B cell activating T  cell as the target of the IL-2, since providing this cell 
in the form of an IL-2-independent T  cell hybridoma did not alleviate the IL-2 
requirement. 
The available evidence suggests that the IL-X activity of FS7 SN in the anti- 
hapten  PFC response  is due to  IFN~.  In the present study this conclusion  was 
supported by the pH sensitivity of its activity. This conclusion is further supported 
by extensive studies of the  lymphokine  activities associated with  Con A  SN of 
FS7-20.6.18  (8).  The  original  hybridoma  FS7-20  produced  five  lymphokine 
activities:  IL-2,  IFN~,  MAF,  IaIF, and the B cell helper activity IL-X.  Analysis 
of a  panel  of clones  and  subclones  of FS7-20  established  that  the  ability  to 
produce IL-2 frequently segregated independently from the other four activities. 
Surprisingly,  the production  of IFNv,  MAF, IaIF, and  IL-X in  these subclones 
did not segregate independently and there was a  high  degree of correlation  in 
the level of each lymphokine activity produced. This result suggested that either 
a  single  lymphokine  mediated  each  of these functions or alternatively,  two or 
more lymphokines were involved, with the genes coding for these lymphokines 
linked and coordinately expressed following Con A activation. Favoring the first 
interpretation  was the observation that each of the lymphokine activities associ- 
ated with FS7 SN was destroyed by pH 2 incubation.  This conclusion has been 
further  supported  by independent  studies  demonstrating  that  preparations  of 
IFN  v potentiate in vitro and in vivo anti-SRBC PFC responses (32), and possess 
IaIF  activity  (33)  and  MAF activity  (34).  Conclusive  identification  of murine 
IFNy as a  B cell helper factor in PFC responses to protein-bound haptens await 
its availability in pure form. 
Summary 
We have demonstrated  the ability of a  series of murine T  cell hybridomas to 
deliver an antigen-specific, B cell I-region-restricted helper signal in the genera- 
tion of specific PFC responses to protein-bound haptens. With some hybridomas ROEHM  ET  AL.  331 
the  elicitation  of optimal  PFC  responses  required  the  addition  of nonspecific 
factors provided by culture supernatants  of concanavalin  A-stimulated (Con A 
SN)  spleen  cells.  Using  hapten-primed  B  cells  depleted  of both  T  cells  and 
macrophages (MO) we have now demonstrated a requirement for three nonspe- 
cific factor preparations  to substitute for spleen Con A  SN in the elicitation  of 
optimal  PFC responses.  The  first preparation  was the interleukin  1 containing 
culture supernatant of the MO tumor cell line P388D1, the second the interleukin 
2 (IL-2) and B cell growth factor containing Con A SN of the T  cell hybridoma 
FS6-14.13, and the third,  the gamma interferon containing Con A SN of the T 
cell  hybridoma  FS7-20.6.18.  The  P388Dl  and  FS6-14.13  factor preparations 
were  most  effective when  added  at  the  initiation  of culture,  while  the  FS7- 
20.6.18  factor preparation  was most effective when added at  24 h  of culture. 
The activity of FS6-14.13 Con A SN was depleted by incubation with the IL-2- 
dependent T cell line HT-2. The activity of FS7-20.6.18 Con A SN was abrogated 
by incubation at pH 2. The results suggest that the generation of PFC responses 
to protein-bound haptens require at least three nonspecific factors in addition to 
an antigen/Ia specific helper signal. 
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